Local Anesthetics Practice Questions

Q: A 25-year-old woman is being treated for a laceration to the forearm. Local anesthesia is used prior to suturing. An allergic reaction is most likely to occur with which of the following local anesthetics?

Procaine. **Explanation:** The core concept behind this question is the chemical classification of local anesthetics (LAs) into **Esters** and **Amides**. **Why Procaine is Correct:** Procaine belongs to the **Ester group** of local anesthetics. Esters are metabolized by plasma pseudocholinesterase into **Para-aminobenzoic acid (PABA)**. PABA is a highly antigenic compound and is the primary culprit behind true allergic reactions (Type I or Type IV hypersensitivity) associated with local anesthesia. Therefore, esters have a much higher potential for allergic reactions compared to amides. **Why the Other Options are Incorrect:** * **Lidocaine, Mepivacaine, and Bupivacaine:** These are all **Amide-linked** local anesthetics. Amides are metabolized in the liver and do not produce PABA. True allergic reactions to amides are extremely rare. When they do occur, they are often attributed to preservatives like *methylparaben* rather than the anesthetic drug itself. **High-Yield NEET-PG Pearls:** * **The "i" Rule:** To distinguish between the two classes, remember that **Amides** have two "i"s in their name (L**i**doca**i**ne, Bup**i**vaca**i**ne, Pr**i**loca**i**ne, Rop**i**vaca**i**ne), while **Esters** have only one "i" (Proca**i**ne, Chloroproca**i**ne, Coca**i**ne, Benzoca**i**ne). * **Cross-reactivity:** There is significant cross-reactivity among different Esters (due to the common PABA metabolite), but there is generally no cross-reactivity between Esters and Amides. * **Drug of Choice:** Lidocaine is the most commonly used LA for minor procedures due to its rapid onset and low allergenic potential. Bupivacaine is preferred for longer duration and labor analgesia but carries a higher risk of cardiotoxicity.

Q: Side effects of lignocaine are all except?

Sedation. **Explanation:** The toxicity of local anesthetics (LAs) like Lignocaine primarily involves the **Central Nervous System (CNS)** and the **Cardiovascular System (CVS)**. Lignocaine toxicity follows a predictable progression of CNS excitation followed by depression. **Why "Sedation" is the correct answer:** While high doses of Lignocaine eventually lead to CNS depression (coma/respiratory arrest), **sedation** is not a typical side effect or a sign of toxicity. In fact, early toxicity is characterized by excitatory symptoms. It is important to note that while some LAs like Procaine may cause sedation, Lignocaine is classically associated with restlessness and agitation. **Analysis of Incorrect Options:** * **Tinnitus:** This is one of the earliest objective signs of systemic toxicity (LAST - Local Anesthetic Systemic Toxicity). Other early signs include perioral numbness and a metallic taste. * **Vomiting:** Nausea and vomiting are common systemic side effects resulting from the stimulation of the chemoreceptor trigger zone (CTZ) or as a precursor to CNS instability. * **Convulsions:** This is a hallmark of moderate-to-severe Lignocaine toxicity. LAs inhibit inhibitory pathways in the brain first, leading to unopposed excitatory activity and tonic-clonic seizures. **NEET-PG High-Yield Pearls:** 1. **Maximum Dose:** Lignocaine plain = 3 mg/kg; with Adrenaline = 7 mg/kg. 2. **Order of Toxicity:** CNS symptoms (Tinnitus → Seizures) always precede CVS symptoms (Bradycardia → Hypotension) with Lignocaine. (Note: Bupivacaine is more cardiotoxic). 3. **Antidote:** Intravenous **Lipid Emulsion (20% Intralipid)** is the specific treatment for LAST. 4. **Drug of Choice:** Lignocaine is the drug of choice for ventricular arrhythmias (Class IB antiarrhythmic).

Q: Which of the following indicates the speed of onset of action of local anesthetics?

Blood : gas partition coefficient. ### Explanation The speed of onset of action for inhalation anesthetics is primarily determined by their **solubility in blood**, which is measured by the **Blood:Gas partition coefficient**. **1. Why Blood:Gas Partition Coefficient is Correct:** The Blood:Gas partition coefficient indicates how much of the anesthetic dissolves in the blood compared to the gas phase. * **Low Solubility (Low Coefficient):** The blood acts as a small reservoir. It saturates quickly, allowing the partial pressure of the gas to rise rapidly in the alveoli and subsequently in the brain, leading to a **fast onset** (e.g., Sevoflurane, Desflurane). * **High Solubility (High Coefficient):** The blood acts as a large "sponge," absorbing a vast amount of the gas. This prevents the partial pressure from rising quickly, leading to a **slow onset** (e.g., Halothane). **2. Why Other Options are Incorrect:** * **Minimum Alveolar Concentration (MAC):** This is a measure of the **potency** of an inhalation anesthetic (equivalent to ED50). It is the concentration required to prevent movement in 50% of patients in response to a surgical stimulus. It does not determine speed. * **Oil:Gas Partition Coefficient:** This correlates with the **lipid solubility** of the agent. According to the Meyer-Overton hypothesis, lipid solubility is directly proportional to potency (MAC). Therefore, it indicates potency, not speed of onset. **3. High-Yield Clinical Pearls for NEET-PG:** * **Potency** $\propto$ Lipid Solubility $\propto$ Oil:Gas Partition Coefficient $\propto$ 1/MAC. * **Speed of Onset** $\propto$ 1/Blood:Gas Partition Coefficient. * **Fastest Onset:** Desflurane (lowest Blood:Gas coefficient ~0.42). * **Slowest Onset:** Halothane (highest Blood:Gas coefficient ~2.4). * **Second Gas Effect:** Using Nitrous Oxide ($N_2O$) alongside a volatile anesthetic speeds up the induction of the second gas.

Q: Which of the following is referred to as the 'chemical tourniquet'?

Adrenaline. **Explanation:** **Why Adrenaline is the Correct Answer:** Adrenaline (Epinephrine) is known as a **'chemical tourniquet'** because of its potent **α1-adrenergic agonist** activity. When added to local anesthetics (LAs), it causes significant vasoconstriction at the site of injection. This action mimics a physical tourniquet by: 1. **Decreasing systemic absorption:** It keeps the anesthetic localized, thereby reducing the risk of systemic toxicity (LAST). 2. **Increasing duration of action:** By slowing down the removal of the drug by the bloodstream, the anesthetic remains in contact with the nerve for a longer period. 3. **Providing a bloodless field:** The vasoconstriction reduces surgical bleeding. **Why Other Options are Incorrect:** * **Hyaluronidase:** This is known as the **'spreading factor.'** It breaks down hyaluronic acid in the connective tissue, increasing the permeability of the tissue. It is used to enhance the diffusion and onset of local anesthetics (commonly in ophthalmic blocks), which is the functional opposite of a tourniquet. * **Option C and D:** Since Adrenaline and Hyaluronidase have antagonistic effects on drug localization, they cannot both be referred to as a chemical tourniquet. **High-Yield NEET-PG Pearls:** * **Standard Concentration:** Adrenaline is typically used in a concentration of **1:200,000** (5 µg/mL) with local anesthetics. * **Contraindications:** Never use Adrenaline in blocks involving **end-arteries** (e.g., fingers, toes, tip of the nose, penis, and pinna of the ear) due to the risk of ischemia and gangrene. * **Maximum Dose:** The addition of Adrenaline allows for a higher maximum permissible dose of LAs (e.g., Lignocaine dose increases from 3 mg/kg to **7 mg/kg**).

Q: Which is the most potent and longest-acting local anesthetic agent?

Dibucaine. **Explanation:** The potency of a local anesthetic (LA) is primarily determined by its **lipid solubility**, while the duration of action is determined by its **protein binding** capacity. **Why Dibucaine is the correct answer:** Dibucaine (a quinoline derivative) is the most potent, most toxic, and longest-acting local anesthetic currently known. It has exceptionally high lipid solubility and protein binding, surpassing even Bupivacaine and Tetracaine. While it is too toxic for most routine clinical applications today, it remains the "gold standard" for potency in pharmacological classifications. **Analysis of Incorrect Options:** * **B. Tetracaine:** An ester-linked LA that is highly potent and long-acting, frequently used for spinal anesthesia. However, its potency and duration are numerically lower than Dibucaine. * **C. Bupivacaine:** An amide-linked LA widely used for its long duration of action (3–6 hours). While it is the most common long-acting agent used *clinically*, it is less potent than Dibucaine. * **D. Lignocaine (Lidocaine):** The prototype amide LA. It is considered an agent of **intermediate potency and duration**. It is the drug of choice for most short procedures and as an anti-arrhythmic. **High-Yield Clinical Pearls for NEET-PG:** * **Dibucaine Number:** Clinically, Dibucaine is used in the "Dibucaine Test" to identify atypical **pseudocholinesterase**. Normal enzyme activity is inhibited by 80% (Dibucaine No. 80), whereas atypical enzyme is inhibited by only 20% (Dibucaine No. 20), leading to prolonged apnea after Succinylcholine administration. * **Potency Rule:** Lipid solubility ∝ Potency. * **Duration Rule:** Protein binding ∝ Duration of action. * **Cardiotoxicity:** Bupivacaine is notorious for being the most cardiotoxic among commonly used LAs.

Q: Which of the following nerve fibers are most susceptible to the action of local anesthetics?

C fibers. **Explanation:** The susceptibility of nerve fibers to local anesthetics (LAs) is governed by the **size of the fiber** and the **presence of myelin**. Generally, smaller fibers and myelinated fibers are blocked more easily than larger, unmyelinated ones. **Why C fibers are the correct answer:** C fibers are the **smallest in diameter** (0.4–1.2 μm) and are **unmyelinated**. While myelination usually increases sensitivity (as seen in B fibers), the extremely small diameter of C fibers allows the local anesthetic to reach a critical blocking concentration across the axonal membrane much faster than in larger fibers. They carry slow pain and temperature sensations. **Analysis of Incorrect Options:** * **A fibers:** These are large, myelinated fibers. Due to their large diameter, they are the most resistant to LA blockade. They are subdivided into alpha (motor), beta (touch/pressure), gamma (muscle spindles), and delta (fast pain). * **B fibers:** These are small, myelinated preganglionic autonomic fibers. In clinical practice, **B fibers are often the first to be blocked** because they are myelinated and small. However, in terms of absolute sensitivity to the drug concentration, C fibers are traditionally considered the most susceptible. * **D fibers:** This is a distractor; there is no "D fiber" in the Erlanger-Gasser classification of nerve fibers. **NEET-PG High-Yield Pearls:** 1. **Order of Blockade (Clinical):** B fibers (Autonomic) > A-delta & C fibers (Pain/Temp) > A-gamma & A-beta (Touch/Pressure) > A-alpha (Motor). 2. **The "3-Node Rule":** For myelinated fibers, at least **three successive Nodes of Ranvier** must be exposed to the LA to interrupt impulse propagation. 3. **Differential Block:** This is the clinical phenomenon where different nerve functions are lost at different times (e.g., losing pain sensation while retaining motor function).

Q: Which of the following statements about lignocaine is FALSE?

It is safe for individuals prone to malignant hyperthermia.. **Explanation:** Lignocaine (Lidocaine) is an amino-amide local anesthetic that acts by blocking voltage-gated sodium channels. **Why Option C is the correct (False) statement:** Historically, there was a theoretical concern that amide local anesthetics could trigger **Malignant Hyperthermia (MH)**. However, extensive clinical evidence and the Malignant Hyperthermia Association of the United States (MHAUS) have confirmed that **all local anesthetics (including lignocaine) are safe** for MH-susceptible patients. The primary triggers for MH are volatile inhalational anesthetics (e.g., Halothane, Sevoflurane) and the depolarizing muscle relaxant Succinylcholine. Therefore, stating it is "unsafe" or a "trigger" is a common misconception often tested in exams. **Analysis of other options:** * **Option A:** Lignocaine is indeed the "gold standard" and the most widely used local anesthetic due to its rapid onset, moderate duration, and versatility (topical, infiltration, nerve blocks, and spinal). * **Option B:** The duration of action for lignocaine infiltration is typically 30–60 minutes. Adding epinephrine (1:200,000) prolongs this to 2–6 hours by causing vasoconstriction, which slows systemic absorption. **High-Yield Clinical Pearls for NEET-PG:** * **Max Dose:** 4 mg/kg (plain) and 7 mg/kg (with adrenaline). * **Anti-arrhythmic:** It is a Class Ib anti-arrhythmic used for ventricular arrhythmias. * **Metabolism:** It is metabolized in the **liver** by cytochrome P450 enzymes (unlike esters, which are metabolized by plasma pseudocholinesterase). * **Toxicity:** Early signs of LAST (Local Anesthetic Systemic Toxicity) include perioral numbness, metallic taste, and tinnitus, progressing to seizures.

Q: ECG changes can first be observed when the level of lignocaine is more than which of the following values?

5-6 ug/ml. ### Explanation Lignocaine (Lidocaine) is an amide local anesthetic that acts by blocking voltage-gated sodium channels. Its toxicity is dose-dependent and follows a predictable progression as plasma concentrations rise, moving from the central nervous system (CNS) to the cardiovascular system (CVS). **1. Why 5–6 µg/ml is correct:** The therapeutic range for lignocaine (e.g., when used as an anti-arrhythmic) is **1.5–5 µg/ml**. Once plasma levels exceed **5 µg/ml**, the drug begins to exert significant inhibitory effects on the cardiac conduction system. Initial ECG changes—such as **PR interval prolongation and QRS widening**—typically manifest at concentrations between **5–10 µg/ml**. **2. Analysis of Incorrect Options:** * **1.2 µg/ml (Option D):** This is below the therapeutic threshold. No toxic effects are observed here. * **2–4 µg/ml (Option C):** This is within the therapeutic range. While mild CNS symptoms (lightheadedness, metallic taste) may begin at the upper end of this range (around 3–5 µg/ml), ECG changes are not yet evident. * **10–12 µg/ml (Option B):** At these high levels, toxicity is severe. This range is associated with profound myocardial depression, bradycardia, AV block, and potentially seizures or coma. **3. Clinical Pearls for NEET-PG:** * **Progression of Toxicity:** CNS symptoms (tinnitus, perioral numbness, seizures) always precede CVS symptoms with lignocaine. This is the opposite of Bupivacaine, where cardiac arrest can occur simultaneously with seizures. * **CC/CNS Ratio:** Lignocaine has a high ratio, meaning it is safer than Bupivacaine (which has a low ratio and is more cardiotoxic). * **Management:** The specific antidote for Local Anesthetic Systemic Toxicity (LAST) is **20% Intravenous Lipid Emulsion (ILE)**. * **Maximum Dose:** 3 mg/kg (plain) and 7 mg/kg (with adrenaline).

Q: Which local anesthetic is commonly used in wound or ulcer management?

Benzocaine. **Explanation:** **Benzocaine** is the correct answer because it is a unique ester-linked local anesthetic characterized by its **very low solubility in water**. Due to this property, it is absorbed too slowly to be given by injection but is highly effective for **topical application** on mucous membranes and denuded skin surfaces (wounds or ulcers). It provides prolonged surface anesthesia without significant systemic toxicity, making it the drug of choice for treating painful skin conditions, mouth ulcers, and as a throat spray before endoscopy. **Analysis of Incorrect Options:** * **Prilocaine (A):** An amide local anesthetic primarily used for infiltration and regional blocks. It is a component of EMLA cream but is not used alone for open wound management. Its major side effect is methemoglobinemia. * **Chloroprocaine (B):** An ester anesthetic with a very short duration of action due to rapid hydrolysis by plasma cholinesterase. It is primarily used for infiltration and epidural anesthesia, not topical wound care. * **Bupivacaine (D):** A potent, long-acting amide anesthetic. It is highly cardiotoxic if absorbed systemically and is used for infiltration, spinal, and epidural anesthesia, but lacks effective topical activity on intact skin or ulcers. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Benzocaine acts by blocking voltage-gated sodium channels, but unlike others, it exists almost entirely in the **unionized form** at physiological pH. * **Side Effect:** Like prilocaine, benzocaine can cause **methemoglobinemia** if used in excessive quantities topically. * **EMLA Cream:** A eutectic mixture of **Lidocaine (2.5%) and Prilocaine (2.5%)** used to anesthetize intact skin before venipuncture. * **Cocaine:** The only local anesthetic with intrinsic **vasoconstrictive** properties; all others are vasodilators (except ropivacaine/levobupivacaine which have mild vasoconstriction).

Question 1

A 25-year-old woman is being treated for a laceration to the forearm. Local anesthesia is used prior to suturing. An allergic reaction is most likely to occur with which of the following local anesthetics?

Accepted Answer

Procaine

Answer

Lidocaine

Answer

Mepivacaine

Answer

Bupivacaine

Question 2

Side effects of lignocaine are all except?

Accepted Answer

Sedation

Answer

Vomiting

Answer

Convulsion

Answer

Tinnitus

Question 3

Which is the first sensation to be lost with the use of local anesthetics?

Accepted Answer

Temperature

Answer

Touch

Answer

Pain

Answer

Pressure

Question 4

Which of the following indicates the speed of onset of action of local anesthetics?

Accepted Answer

Blood : gas partition coefficient

Answer

Minimum alveolar concentration

Answer

Oil : gas partition coefficient

Answer

None of the above

Question 5

Which of the following is referred to as the 'chemical tourniquet'?

Accepted Answer

Adrenaline

Answer

Hyaluronidase

Answer

Both Adrenaline and Hyaluronidase

Answer

None of the above

Question 6

Which is the most potent and longest-acting local anesthetic agent?

Accepted Answer

Dibucaine

Answer

Tetracaine

Answer

Bupivacaine

Answer

Lignocaine

Question 7

Which of the following nerve fibers are most susceptible to the action of local anesthetics?

Accepted Answer

C fibers

Answer

A fibers

Answer

B fibers

Answer

D fibers

Question 8

Which of the following statements about lignocaine is FALSE?

Accepted Answer

It is safe for individuals prone to malignant hyperthermia.

Answer

It is the most commonly used anesthetic agent.

Answer

It provides anesthesia for 45–60 minutes without epinephrine.

Answer

None of the above.

Question 9

ECG changes can first be observed when the level of lignocaine is more than which of the following values?

Accepted Answer

5-6 ug/ml

Answer

10-12 ug/ml

Answer

2-4 ug/ml

Answer

1.2 ug/ml

Question 10

Which local anesthetic is commonly used in wound or ulcer management?

Accepted Answer

Benzocaine

Answer

Prilocaine

Answer

Chloroprocaine

Answer

Bupivacaine

Local Anesthetics — MCQs

Local Anesthetics — MCQs

On this page

Practice by Chapter

Want unlimited practice?